NMTC

NeuroOne Medical Technologies Corporation Common Stock

0.77

USD

NMTC Earnings Reports

Positive Surprise Ratio

NMTC beat 14 of 17 last estimates.

82%

Next Report

Date of Next Report

May 11, 2026

Estimate for Q2 26 (Revenue/ EPS)

$2.63M

-$0.03

Implied change from Q1 26 (Revenue/ EPS)

-9.15%

Implied change from Q2 25 (Revenue/ EPS)

+89.05%

-57.14%

NeuroOne Medical Technologies Corporation Common Stock earnings per share and revenue

On Feb 17, 2026, NMTC reported earnings of -0.03 USD per share (EPS) for Q1 26, beating the estimate of -0.04 USD, resulting in a 26.47% surprise. Revenue reached 2.89 million, compared to an expected 2.73 million, with a 5.90% difference. The market reacted with a -16.50% price change (close before vs. close after earnings).

Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.03 USD, with revenue projected to reach 2.63 million USD, implying an increase of 0.00% EPS, and decrease of -9.15% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

IceCure Medical Ltd. Ordinary Shares

Report Date

Mar 17, 2026 For Q4 25

Estimate

-$0.04

Actual

-$0.07

Surprise

-52.51%

Lifeward Ltd. Ordinary Shares

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$1.10

Actual

-$3.60

Surprise

-226.80%

SeaStar Medical Holding Corporation Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$1.07

Actual

-$0.80

Surprise

+25.28%

Healthy Choice Wellness Corp.

Report Date

Mar 16, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.05

Surprise

+1.96%

Aclarion, Inc. Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$3.67

Actual

-$2.54

Surprise

+30.83%

HealthEquity, Inc

Report Date

Mar 17, 2026 For Q4 26

Estimate

$0.90

Actual

$0.95

Surprise

+4.51%

The Oncology Institute, Inc. Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.09

Actual

-$0.06

Surprise

+33.99%

The Beauty Health Company Class A Common Stock

Report Date

Mar 12, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.06

Surprise

-14.29%

Sera Prognostics, Inc. Class A Common Stock

Report Date

Mar 18, 2026 For Q4 25

Estimate

-$0.19

Actual

-$0.16

Surprise

+17.44%

DocGo Inc. Common Stock

Report Date

Mar 16, 2026 For Q4 25

Estimate

-$0.13

Actual

-$1.37

Surprise

-920.10%

FAQ

What were NeuroOne Medical Technologies Corporation Common Stock's earnings and revenue for the latest quarter Q1 2026?

For Q1 2026, NeuroOne Medical Technologies Corporation Common Stock reported EPS of -$0.03, beating estimates by 26.47%, and revenue of $2.89M, 5.9% above expectations.

How did the market react to NeuroOne Medical Technologies Corporation Common Stock's Q1 2026 earnings?

The stock price moved down -16.5%, changed from $0.81 before the earnings release to $0.68 the day after.

When is NeuroOne Medical Technologies Corporation Common Stock expected to report next?

The next earning report is scheduled for May 11, 2026.

What are the forecasts for NeuroOne Medical Technologies Corporation Common Stock's next earnings report?

Based on 4 analysts, NeuroOne Medical Technologies Corporation Common Stock is expected to report EPS of -$0.03 and revenue of $2.63M for Q2 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.